NCT00902421View on ClinicalTrials.gov

Efficacy and Safety of Selective Serotonin Reuptake Inhibitor (SSRI) in Overactive Bladder Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Overactive Bladder
Interventions
DRUG

Selective serotonin reuptake inhibitors

escitalopram 10mg once daily for 3 months

DRUG

Antimuscarinics

Antimuscarinics for 3 months

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT00902421 - Efficacy and Safety of Selective Serotonin Reuptake Inhibitor (SSRI) in Overactive Bladder Patients | Biotech Hunter | Biotech Hunter